Otolaryngology · Flint, MI
NPI
1104876028
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1170 Charter Dr, Suite F
Flint, MI, 48532
Phone (810) 244-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
718 services
Medicare patients, 2024
567
Average age 77
Drug cost, 2024
$14K
320 prescriptions
Company payments, 2025
$13.76
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srinivas B Mukkamala was code 99213 (office e&m - established), 367 times for 238 patients. In total Srinivas B Mukkamala billed 718 services in 15 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 367 | 238 | $57.85 | $21K |
| 99203 Office E&M - New | Office | 257 | 257 | $65.52 | $17K |
| 31575 Other Organ Systems | Office | 55 | 55 | $85.35 | $4,694 |
| 30901 Other Organ Systems | Office | 11 | 11 | $144.73 | $1,592 |
By year: 2022 $72K for 1,197 services; 2023 $61K for 920 services; 2024 $47K for 718 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srinivas B Mukkamala prescribed most often to Medicare patients was Ipratropium Bromide, with 116 prescriptions and refills. In total Srinivas B Mukkamala wrote 320 Medicare prescriptions that cost $14K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 116 | 143 | 41 | $3,614 |
| Neomycin-Polymyxin-Hydrocort Neomycin/Polymyxin B/Hydrocort | 95 | 95 | 53 | $5,813 |
| Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort | 28 | 28 | 14 | $1,648 |
Brand drugs: - claims; generic drugs: 311 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srinivas B Mukkamala $13.76 ($13.76 in general payments such as food, travel and fees) from 1 company. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $13.76.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $13.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.